Uncategorized Archives - Frier Levitt

The Impact of PCMA v. Mulready Decision on Independent Pharmacies

A.J. Barbarito, Esq. and Geordan L. Ferguson, Esq. August 24, 2023

The Tenth Circuit Court of Appeals delivered a disappointing result for both independent pharmacies and state-level efforts to tackle abusive practices by Pharmacy Benefit Managers (PBMs), including efforts to prevent patient “steering.” On... Read More

Jonathan Levitt Opening Statement before United States Senate Committee on Finance Regarding Drug Supply Chain

Frier Levitt May 12, 2023

Frier Levitt Co-Founding Partner Jonathan Levitt was recently invited to testify before the U.S. Senate Committee on Finance during its hearing titled “Pharmacy Benefit Managers and the Prescription Drug Supply Chain: Impact on Patients and... Read More

News | Uncategorized

WATCH: Jonathan Levitt Testifies Before U.S. Senate Committee on Finance: “Pharmacy Benefit Managers and the Prescription Drug Supply Chain Impact on Patients and Taxpayers”

Frier Levitt April 28, 2023

Frier Levitt co-founding partner, Jonathan Levitt testified before the U.S. Senate Committee on Finance on March 30, 2023 at a hearing titled "Pharmacy Benefit Managers and the Prescription Drug Supply Chain: Impact on Patients and... Read More

Uncategorized

Navigating the Latest PBM Audit Trends: Insights and Strategies for Success

Dae Y. Lee, Pharm.D., Esq., CPBS and Lucas W. Morgan, Esq. February 20, 2023

Frier Levitt Partners Dae Lee and Lucas Morgan host a webinar exclusively for PARD members. Viewers of this webinar will learn: How to prepare for pharmacy benefit manager (PBM) audits How to effectively challenge PBM audits, if necessary... Read More

Uncategorized

Webinar: What You Need to Know if You are Being Investigated by the Government

Anthony J. Mahajan, Esq. December 14, 2022

Healthcare is one of the most highly regulated industries with numerous laws and regulations affecting physicians and their practices. In this webinar, Frier Levitt attorney Anthony J. Mahajan, Esq., a decorated former federal prosecutor with the... Read More

On-Demand Webinars | Uncategorized

Frier Levitt CICP Update December 2022

Frier Levitt December 9, 2022

On December 9, 2022, Frier Levitt hosted a brief virtual session regarding CICP program updates. Frier Levitt Co-Founding Partner Jonathan Levitt and Partner Michelle Greenberg provided updates on the number of claims filed, decisions, and our... Read More

Uncategorized

PBM Audit Trends & Preemptive Strategies for the Year Ahead

Dae Y. Lee, Pharm.D., Esq., CPBS and Matthew A. Benzoni, Esq. December 7, 2022

As the Pharmacy Benefit Managers (PBMs) prepare for the end-of-year “housekeeping”, pharmacies should be aware of the PBM audit trends and arm themselves with information necessary to preempt—and strategies to outright avoid—falling victim... Read More

PHARMACY ALERT: Express Scripts Offers Pharmacies Another Opportunity to Rejoin TRICARE Network on December 1, 2022

Dae Y. Lee, Pharm.D., Esq., CPBS and Conor R. McCabe, Esq. December 1, 2022

Frier Levitt has been closely monitoring Express Scripts’ (“ESI”) administration of TRICARE, the health care program for uniformed service members and their families. Earlier this year the Defense Health Agency (“DHA”) awarded ESI a... Read More

PHARMACY ALERT: Importance of Disclosing Accurate Ownership Information to PBMs

Jessica L. Missel, Esq. and Harini Bupathi, Esq. September 27, 2022

Pharmacy Benefit Managers (PBMs) routinely request that pharmacies submit credentialing and re-credentialing applications, which require pharmacies to provide complete ownership information. In addition, PBMs require that pharmacies identify any... Read More

How to Prepare for a PBM Audit to Avoid Common Pitfalls

Dae Y. Lee, Pharm.D., Esq., CPBS and Harini Bupathi, Esq. May 19, 2022

Frier Levitt attorneys Dae Y. Lee, PharmD, Esq., CPBS and Harini Bupathi, Esq., present a webinar that discusses trends, proactive measures, audit triggers, and most importantly, tools available for pharmacies to defend against PBM audits. As... Read More

Uncategorized

Category: Uncategorized

The Impact of PCMA v. Mulready Decision on Independent Pharmacies

Jonathan Levitt Opening Statement before United States Senate Committee on Finance Regarding Drug Supply Chain

WATCH: Jonathan Levitt Testifies Before U.S. Senate Committee on Finance: “Pharmacy Benefit Managers and the Prescription Drug Supply Chain Impact on Patients and Taxpayers”

Navigating the Latest PBM Audit Trends: Insights and Strategies for Success

Webinar: What You Need to Know if You are Being Investigated by the Government

Frier Levitt CICP Update December 2022

PBM Audit Trends & Preemptive Strategies for the Year Ahead

PHARMACY ALERT: Express Scripts Offers Pharmacies Another Opportunity to Rejoin TRICARE Network on December 1, 2022

PHARMACY ALERT: Importance of Disclosing Accurate Ownership Information to PBMs

How to Prepare for a PBM Audit to Avoid Common Pitfalls

Value Based Care insights

Let us help you find solutions.

Sign up for our newsletter